|
TMV Vaccine Clinical Trials
1 actively recruiting trial across 1 location
Also known as: MTC-Vaccine-P, Membrex, Tumor Membrane Vesicle Vaccine
Pipeline
Phase 1: 1
Top Sponsors
- Metaclipse Therapeutics Corporation1
Indications
- Squamous Cell Carcinoma of Head and Neck (SCCHN)1
- Neoplasm Recurrence, Local1
- Recurrent Head and Neck Squamous Cell Carcinoma1
- Squamous Cell Carcinoma of Head and Neck1
- HNSCC1
Houston, Texas1 trial
TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell Carcinoma
The University of Texas MD Anderson Cancer Center
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.